ZYNE Forecast and Technical Stock Analysis
Sell candidate since 2019-08-08 Loss -0.44%
Zynerba Pharmaceuticals gained 5.46% in the last trading day ( Friday, 16th Aug 2019 ), rising from $10.62 to $11.20 During the day the stock fluctuated 6.28% from a day low at $10.67 to a day high of $11.34. The price has fallen in 6 of the last 10 days , but is still up by 10.24% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 199 060 more shares were traded than the day before. In total, 671 849 shares bought and sold for approximately $7.52 million.
- 30 day high of the ZYNE stock price was $13.77 and low was $9.41.
- 90 day high was $15.70 and low was $9.41.
- 52 week high for Zynerba Pharmaceuticals - $16.46 and low - $2.75.
Zynerba Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -16.75% during the next 3 months and, with 90% probability hold a price between $6.72 and $11.73 at the end of this period.
A buy signal was issued from a pivot bottom point on Thursday August 15, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. Zynerba Pharmaceuticals holds a buy signal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $12.11. On a fall, the stock will find some support from the short-term average at $10.94. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 54 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Zynerba Pharmaceuticals finds support from accumulated volume at $11.10.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.67 between high and low, or 6.28%. For the last week, the stock has had a daily average volatility of 5.70%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
5.70 %Average volatility
Very Low Low Medium High Very High
|ZYNE $11.20 ($0.58 5.46%)|
ZYNE is up $0.58 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ZYNE based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ZYNE analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!